T o o muc h me dic ine a nd ve no us thro mb o e mb o lism: Ho w - - PowerPoint PPT Presentation

t o o muc h me dic ine a nd ve no us thro mb o e mb o
SMART_READER_LITE
LIVE PREVIEW

T o o muc h me dic ine a nd ve no us thro mb o e mb o lism: Ho w - - PowerPoint PPT Presentation

T o o muc h me dic ine a nd ve no us thro mb o e mb o lism: Ho w c a n we ma ke thing s We ll a g a in? E mily G Mc Do na ld MD MSc ; Assista nt pro fe sso r o f me dic ine ; Mc Gill Unive rsity He a lth Ce ntre Ca na dia n So c ie


slide-1
SLIDE 1

T

  • o muc h me dic ine a nd

ve no us thro mb o e mb o lism: Ho w c a n we ma ke thing s “We ll” a g a in?

E mily G Mc Do na ld MD MSc ; Assista nt pro fe sso r o f me dic ine ; Mc Gill Unive rsity He a lth Ce ntre Ca na dia n So c ie ty o f Inte rna l Me dic ine ; No ve mb e r, 2017; T

  • ro nto , Ca na da
slide-2
SLIDE 2

Ob je c tive s:

 De sc rib e the ro o t o f the pro b le m: o ve rd ia g no sis a nd

  • ve rtre a tme nt o f ve no us thro mb o e mb o lism

 Ca se o f CT

pulmo na ry a ng io g ra m (a nd ve no us Do pple r)

  • ve ruse

 Disc uss whe n a ntic o a g ula tio n ma y no t b e re q uire d  Disc uss pra c titio ne r va ria b ility in the inve stig a tio n o f VT

E

 Re d uc e o ve r-inve stig a tio n, o ve rd ia g no sis, a nd

  • ve rtre a tme nt o f VT

E within yo ur pra c tic e

slide-3
SLIDE 3

Co nflic ts o f inte re st:

 Inte lle c tua l inte re st in re d uc ing o ve ruse a nd

  • ve rtre a tme nt a nd ”wind ing b a c k the ha rms o f to o

muc h me d ic ine ”

 Gra nts re c e ive d fro m the Ca na d ia n Institute s o f He a lth

Re se a rc h a nd the Ca na d ia n F ra ilty Ne two rk to stud y d e pre sc rib ing a nd c o -c re a to r o f Me d Sa fe r, a to o l to sto p me d ic a tio ns in o ld e r a d ults (pa te nt pe nd ing )

 I’ m no t a n e xpe rt in thro mb o sis  I’ ve no t e ve r ta ke n o r re c e ive d pha rma -re la te d

mo ne y/ me rc ha nd ise

slide-4
SLIDE 4

T hro mb o sis: a b it o f histo ry

 F

irst writte n re fe re nc e : in a nc ie nt Ind ia n me d ic a l te xts, physic ia n a nd surg e o n Susruta (c irc a 600 BCE ) d e sc rib e s a pa tie nt with a pa inful swo lle n le g tha t is d iffic ult to tre a t.

 Mid -1800s, Je a n Cruve ilhie r, pro mine nt F

re nc h pa tho lo g ist, pro po se d a c e ntra l ro le fo r ve no us infla mma tio n a nd thro mb o sis in a ll d ise a se c o nd itio ns “phle b itis d o mina te s a ll o f pa tho lo g y”

slide-5
SLIDE 5

And who is this?

slide-6
SLIDE 6

Rudo lph Virc ho w

slide-7
SLIDE 7

Virc ho w’ s tria d

slide-8
SLIDE 8

Onc e the pa tho lo g y wa s ide ntifie d, the c ha lle ng e b e c a me dia g no sis. Histo ry o f the dia g no sis o f pulmo na ry e mb o lism

slide-9
SLIDE 9

Dia g no sis o f PE

 Prio r to the 1960s the c linic al d ia g no sis wa s ne ithe r

se nsitive no r spe c ific

 E

K G (S1Q3T 3), CXR (we ste rma rk’ s sig n a nd Ha mpto n’ s hump), physic a l e xa m

slide-10
SLIDE 10

Re f: Da le n JE , Alpe rt JS. Na tura l histo ry o f pulmo na ry e mb o lism. Pro g Ca rdio va sc Dis 1975;17:259–70

slide-11
SLIDE 11

Dia g no sis o f pulmo na ry e mb o lism

 Pulmo na ry a ng io g ra ms (first c a se se rie s 1964)  L

ung sc a n (1960s)

slide-12
SLIDE 12

Pulmo na ry Ang io g ra phy in PE

 Wa s the “g o ld sta nd a rd ”; a ne g a tive pulmo na ry

a ng io g ra m e xc lud e s c linic ally r

e le vant PE

.

 Inva sive me tho d a nd no lo ng e r pe rfo rme d re pla c e d

b y CT a ng io g ra m sinc e 2000 in E uro pe a nd 2006 in No rth Ame ric a

slide-13
SLIDE 13

Ve ntila tio n-Pe rfusio n Sc a ns

 Use ful if no rma l (ne g a tive pre d ic tive va lue o f

97%)

 Also use ful if High pr

  • bability (po sitive

pre d ic tive va lue o f 85 to 90%)

 Unfo rtuna te ly, o nly d ia g no stic in 30 to 50% o f

pa tie nts

slide-14
SLIDE 14

 PIOPE

D stud y (1990 JAMA)--> the impo rta nc e o f pre -te st pro b a b ility

In this la nd ma rk tria l we le a rn: the c o mb ina tio n o f hig h

c linic a l pro b a b ility a nd a hig h pro b a b ility sc a n e q ua ting to the pre se nc e o f PE a nd a lo w c linic al pro b a b ility with a lo w pro b a b ility sc a n e xc lud ing PE

slide-15
SLIDE 15
slide-16
SLIDE 16

Ve ntila tio n-pe rfusio n sc a ns

 De spite PIOPE

D 2, c o nc e rns a b o ut spe c ific ity o f V/ Q

 re po rting po sitive o r ne g a tive finding s in sha de s of g r

a y

 Only dia g no stic in 30 to 50% o f pa tie nts  Clinic ia ns c o ntinue d to se a rc h fo r a ye s/ no te st fo r a c ute PE

 CT CT rapidl idly evolv lved t to fill t ll this rol

  • le

 We re it no t fo r de finite a lle r

g ic a nd ne phr

  • toxic r

isks o f

c o ntra st me dia a nd the a dde d r

a dia tion b urde n o f MDCT

A, the ve ntila tio n/ pe rfusio n sc a n wo uld virtua lly disa ppe a r fro m the dia g no stic a lg o rithm fo r pulmo na ry e mb o lism.

slide-17
SLIDE 17

CT sc a ns- impro ve me nts me a n g re a te r de te c tio n ra te

 In 1992, Re my-Ja rd in re po rte d the use o f spira l CT

sc a nning fo r c e ntra l PE . T he stud y c o nc lud e d tha t spira l CT ha d a se nsitivity o f 100% a nd spe c ific ity o f 96% fo r a d ia g no sis o f c e ntra l PE .

 In 1995, Go o d ma n a nd c o lle a g ue s--> CT

se nsitivity 86%, spe c ific ity 92%, a nd like liho o d ra tio 10.7.

 Whe n subse gme ntal ve sse ls we r

e inc lude d, howe ve r , se nsitivity was 63% , spe c ific ity 89% , and like lihood r atio 5.7.

slide-18
SLIDE 18

Ca se o f o ve r-inve stig a tio n a nd

  • ve rdia g no sis

 With this in mind le t’ s c o nside r a c a se

slide-19
SLIDE 19

Ca se e xa mple o f o ve r-inve stig a tio n

 40 fe ma le with no pa st me d ic a l histo ry o n the o ra l

c o ntra c e ptive pill pre se nts to a c o mmunity c linic a fte r a flig ht ho me fro m F ra nc e with ne w le ft c a lf pa in

slide-20
SLIDE 20
slide-21
SLIDE 21
slide-22
SLIDE 22

I mpre ssio n a nd pla n:

 “Hig h risk fo r DVT

a nd PE ” ( like ly b e c a use o f the histo ry

  • f a irpla ne tra ve l)

 No me ntio n o f the We ll’ s sc o re  CT

pulmo na ry a ng io g ra m is pe rfo rme d

 No CXR  No D-d ime r  No d o pple r

slide-23
SLIDE 23

CT

  • Pulmo na ry e mb o lus

 De spite two inje c tions, the bolus of c ontr

ast is le ss than ade quate fo r a sse ssing se g me nta l a nd sub se g me nta l

b ra nc he s. No filling d e fe c ts id e ntifie d within the ma in pulmo na ry a rte rie s.

 T

he re is a q ue stio na b le filling d e fe c t in a la te ra l lo we r lo b e se g me nta l b ra nc h se e ima g e 151 se rie s 5.

 If pulmo nary e mb o lism str

  • ngly suspe c te d wo uld

re c o mme nd a re pe at e xaminatio n in this patie nt o r a ve ntilatio n pe rfusio n sc an.

slide-24
SLIDE 24

CT PA fo r sub se g me nta l PE

F a lse Po sitive Appa re nt filling de fe c ts L ung windo w re ve a ls mo tio n a rtifa c t

slide-25
SLIDE 25

CT PA fo r sub se g me nta l PE

F a lse Po sitive / Re pro d uc ib ility

T he r e is r e lative ly poor inte r

  • bse r

ve r agr e e me nt for subse gme ntal and/ or small pulmonar y ar te r y de fe c ts, e spe c ially in CT pulmonar y angiogr ams de gr ade d by te c hnic al ar tifac ts.

slide-26
SLIDE 26

T a ke ho me po int:

 CT

PA a s first-line ima g ing fo r suspe c te d pulmo na ry e mb o lism c a n inc re a se the d e te c tio n o f sma ll, sub se g me nta l pulmo na ry e mb o lism, whic h mig ht ha ve a q ue stio na b le c linic al re le va nc e (fa lse po sitive / o ve rd ia g no sis)

slide-27
SLIDE 27

A c a se inspire s a study

slide-28
SLIDE 28

Study pe rfo rme d a t the MUHC

 We re tro spe c tive ly re vie we d a ll CT

PA a t a n a c a d e mic te a c hing ho spita l in Mo ntré a l, Ca na d a , fro m Se pte mb e r 2014 to Ja nua ry 2016.

 A to ta l o f 1394 e xaminations or

de r e d by 182 physic ians we r e inc lude d, of whic h 199 (14.3% ) we r e positive. A multiva ria b le

lo g istic re g re ssio n a na lysis wa s pe rfo rme d to e xplo re whe the r physic ia n spe c ia lty, ye a rs in pra c tic e , physic ia n se x, o r to ta l numb e rs o f stud ie s o rd e re d pe r physic ia n we re a sso c ia te d with CT PA d ia g no stic yie ld .

Cho ng J, L e e T , Siva kuma ra n L , Ga llix B, Mc Dona ld E

G; a c c e pte d fo r pub lic a tio n

No v 1st, 2017; JAMA inte rna l me dic ine (IN PRE SS)

slide-29
SLIDE 29

Study pe rfo rme d a t the MUHC

 Via GE

E lo g istic re g re ssio n, the odds of a positive CT

PA de c r e ase d as the total numbe r

  • f sc ans or

de r e d pe r physic ian inc r e ase d.

 F

  • r

e ac h additional te n studie s or de r e d, the odds of a positive r e sult de c r e ase d [OR 0.76; (95% CI 0.73- 0.79)].

Cho ng J, L e e T , Siva kuma ra n L , Ga llix B, Mc Dona ld E

G; a c c e pte d fo r pub lic a tio n

No v 1st, 2017; JAMA inte rna l me dic ine (IN PRE SS)

slide-30
SLIDE 30

T ABL E 1: Positive CT PA E xa mina tions for All Physic ia ns T a b le o f the Numb e r o f Physic ia ns, Studie s, a nd Numb e r/ Pe rc e nta g e o f Po sitive CT PA with Ma jo r Spe c ia lty Gro uping s. Physic ia ns we re stra tifie d b y the to ta l study vo lume the y

  • rde re d during the o b se rva tio n pe rio d.

Stud y Vo lume Numb e r o f Physic ia ns Numb e r o f CT PA Stud ie s Numb e r o f Po sitive CT PA (%) Physic ia n Sp e c ia lty Gro up : ER, Othe r (%) 1-10 145 411 85 (20.7) ER: 13 (9.0) Othe r: 132 (91.0) 11-20 14 228 37 (16.2) ER: 8 (57.1) Othe r: 6 (42.9) 21-30 9 198 30 (15.2) ER: 8 (88.9) Othe r: 1 (11.1) 31-40 6 179 20 (11.2) ER: 5 (83.3) Othe r: 1 (16.7) 41-50 5 219 19 (8.7) ER: 5 (100.0) > 50 3 159 8 (5.0) ER: 3 (100.0) T OT AL 182 1,394 199 (14.2) ER: 42 (23.1) Othe r: 140 (76.9)

Cho ng J, L e e T , Siva kuma ra n L , Ga llix B, Mc Donald E

G; a c c e pte d fo r pub lic a tio n: No v 1st, 2017;

JAMA inte rna l me dic ine (IN PRE SS)

slide-31
SLIDE 31

T ABL E 1: Positive CT PA E xa mina tions for All Physic ia ns T a b le o f the Numb e r o f Physic ia ns, Studie s, a nd Numb e r/ Pe rc e nta g e o f Po sitive CT PA with Ma jo r Spe c ia lty Gro uping s. Physic ia ns we re stra tifie d b y the to ta l study vo lume the y

  • rde re d during the o b se rva tio n pe rio d.

Stud y Vo lume Numb e r o f Physic ia ns Numb e r o f CT PA Stud ie s Numb e r o f Po sitive CT PA (%) Physic ia n Sp e c ia lty Gro up : ER, Othe r (%) 1-10 145 411 85 (20.7) ER: 13 (9.0) Othe r: 132 (91.0) 11-20 14 228 37 (16.2) ER: 8 (57.1) Othe r: 6 (42.9) 21-30 9 198 30 (15.2) ER: 8 (88.9) Othe r: 1 (11.1) 31-40 6 179 20 (11.2) ER: 5 (83.3) Othe r: 1 (16.7) 41-50 5 219 19 (8.7) ER: 5 (100.0) > 50 3 159 8 (5.0) ER: 3 (100.0) T OT AL 182 1,394 199 (14.2) ER: 42 (23.1) Othe r: 140 (76.9)

Cho ng J, L e e T , Siva kuma ra n L , Ga llix B, Mc Donald E

G; a c c e pte d fo r pub lic a tio n: No v 1st, 2017;

JAMA inte rna l me dic ine (IN PRE SS)

E ight e me r ge nc y r

  • om physic ians in the institution ar

e r e sponsible for

  • r

de r ing mor e than 1/ 3 of the institution’s sc ans! And the ir yie ld is L OW! <9%

slide-32
SLIDE 32

MUHC Study o n CT PA

 Our institutio na l yie ld wa s 14.3% (simila r to prio r re po rte d

stud ie s). Ho we ve r, c lo se r inspe c tio n d e mo nstra te d tha t the re wa s substantial inte r

  • physic ian var

iability, with ind ivid ua l positivity r ate s r anging be twe e n 0% to 33.3% .

 T

AK E HOME ME SSAGE : Pe e r-re la tive ra te s o f utiliza tio n a re e a sily q ua ntifie d fro m e le c tro nic d a ta b a se s, a nd c a n id e ntify physic ia ns mo st like ly to b e ne fit fro m ind ivid ua l pe rfo rma nc e fe e d b a c k a nd d e c isio n suppo rt to o ls (a t the MUHC this a pro g ra m we a re wo rking o n instituting ).

Cho ng J, L e e T , Siva kuma ra n L , Ga llix B, Mc Dona ld E

G; a c c e pte d fo r pub lic a tio n

No v 1st, 2017; JAMA inte rna l me dic ine (IN PRE SS)

slide-33
SLIDE 33

Stra tify a ll pa tie nts a c c o rding to a n

  • b je c tive c linic a l pro b a b ility a sse ssme nt
  • 10 ye a r

s a g o  stra tify a c c o rding to a n o b je c tive

c linic a l pro b a b ility a sse ssme nt;

  • D- dime r

for low or inte r me dia te r isk

slide-34
SLIDE 34
slide-35
SLIDE 35

Ove rre lia nc e o n inve stig a tive ima g ing ma y le a d to se ve ra l ine ffic ie nc ie s in he a lthc a re de live ry

 Inc re a se d pa tie nt wa iting time  Oppo rtunity c o st  Dire c t a nd indire c t fina nc ia l c o sts  Ha rm re la te d to the de te c tio n a nd tre a tme nt o f

fa lse po sitive s o r finding s o f unc le a r sig nific a nc e , suc h a s iso la te d dista l DVT Whe n pa tie nts a re a ppro pria te ly se le c te d fo r Do pple r ultra so und, the po sitivity ra te fo r pro xima l DVT studie s is e xpe c te d to b e o n the o rde r o f 10-20%.

slide-36
SLIDE 36

Pra c titio ne r va ria b ility o f Do pple r ultra so und po sitivity ra te s a s a n indic a to r o f o ve ruse : a re tro spe c tive c o ho rt study

 Re tro spe c tive ly re vie we d a ll lo we r e xtre mity Do pple r ultra so unds

pe rfo rme d o ve r a pe rio d o f 18 mo nths a t the Mo ntre a l Ge ne ra l Ho spita l, Ca na da . Physic ia ns o rde ring >10 e xa mina tio ns o ve r the study pe rio d we re inc lude d.

Ac ute DVT wa s ide ntifie d in 394/ 2030 studie s (16·5%). T he re wa s ma rke d va ria b ility in po sitivity ra te b y physic ia n (ra ng e 0%-42·9%). Of 79 pra c titio ne rs who o rde re d ≥10 e xa mina tio ns o ve r the study pe rio d, one in four a c hie ve d a positivity ra te a bove 15% , while one

in thre e ha d a positivity ra te be low 5% Mc Do na ld, Siva kuma ra n*, Cho ng , Ga llix, L e e ; unde r re vie w Annals o f I nte rnal Me dic ine *c o -first a utho r

slide-37
SLIDE 37

Pro po rtio n o f physic ia ns—b y spe c ia lty—who se po sitivity ra te s fo r dia g no sing pro xima l DVT fa ll within g ive n inte rva ls

10 20 30 40 50 60 ER Medicine Surgery

Proportion of physicians within a given range

  • f positivity rates (%)

Specialty 0% 1-10% 11-15% >15%

slide-38
SLIDE 38

T a ke ho me me ssa g e

 Ste p 1: Do yo u think this pa tie nt ha s a PE

  • r DVT

?

 If yo u DON’ T

think this pa tie nt ha s a DVT

  • r PE

the n ST OP he re .

 Ste p 2: If yo u d o think the re is a po ssib ility o f a PE

  • r DVT

the n pro c e e d to use a c linic al pre d ic tio n to o l (e x. We ll’ s sc o re o r the PE RC sc o re )

 Ste p 3: Ba se d o n the pre -te st pro b a b ility, pro c e e d to D-

d ime r o r a ppro pria te ima g ing

slide-39
SLIDE 39

Whe n in do ub t, fo llo w the te ne ts

  • f the Cho o sing

Wise ly ST ARS!

slide-40
SLIDE 40

Ca se re so lutio n

 3 Do pple r ultra so und s (a ll ne g a tive )  1 CT

pulmo na ry a ng io g ra m (ind e te rmina te )

 2 Ve ntila tio n Pe rfusio n stud ie s (ind e te rmina te a nd the n

ne g a tive )

 Re c o mme nd e d a g a inst a ntic o a g ula tio n  Riva ro xa b a n sto ppe d a fte r 10 d a ys o f tre a tme nt  No b le e d ing o r thro mb o tic c o mplic a tio ns o ve r the

sub se q ue nt thre e mo nths

slide-41
SLIDE 41

Ove rtre a tme nt

slide-42
SLIDE 42

Antithro mb o tic the ra py fo r VT E dise a se : CHE ST g uide line 2016 upda te

 F

  • r pa tie nts with sub se g me nta l PE

a nd no DVT , the g uid e line sug g e sts c linic al sur

ve illanc e ove r antic oagulation whe n the r isk of VT E r e c ur r e nc e is low

(Gra d e 2C).

 T

he g uid e line re c o mme nd s the use o f a ntic o a g ula tio n

  • ve r surve illa nc e whe n the risk o f VT

E re c urre nc e is hig h (Gra d e 2C).

 F

r

  • m loc al data: 87% of our

SSPE s ar e antic oagulate d (72/ 82).

slide-43
SLIDE 43

Wha t is the risk fo r pro g re ssio n o r re c urre nc e ?

 No t ho spita lize d (i.e . o utpa tie nts)  No t immo b ilize d  No a c tive ma lig na nc y  Othe r fa c to rs: Pa tie nt pre fe re nc e L

  • w c a rd io pulmo na ry re se rve

Ab se nc e o f a n a lte rna tive e xpla na tio n fo r sympto ms RISK

OF BL E E DING

slide-44
SLIDE 44

Wha t is the risk fo r pro g re ssio n o r re c urre nc e ?

 No t ho spita lize d (i.e . o utpa tie nts)  No t immo b ilize d  No a c tive ma lig na nc y  Othe r fa c to rs: Pa tie nt pre fe re nc e L

  • w c a rd io pulmo na ry re se rve

Ab se nc e o f a n a lte rna tive e xpla na tio n fo r sympto ms RISK

OF BL E E DING

Any r isk of ble e ding in the abse nc e of a T RUE PE is like ly unac c e ptable !

slide-45
SLIDE 45

I mpro ving yo ur T RUE po sitive s

Ma rke d, une xpla ine d high d- dime r Hig h pr

e - te st pr

  • bability a nd symptomatic

T

he CT is g o o d q ua lity with good opac ific ation o f the dista l a rte rie s

T

he re a re multiple filling de fe c ts with c o ntra st a ro und the de fe c t

De fe c ts invo lve la rg e r sub se g me nta l a rte rie s Se e n o n mor

e than one image , mo re tha n o ne

pro je c tio n

slide-46
SLIDE 46

Ha ve we me t o ut o b je c tive s?

 De sc rib e the ro o t o f the pro b le m: o ve rdia g no sis a nd

  • ve rtre a tme nt o f ve no us thro mb o e mb o lism--> CT

PA ha s be c ome mor e a nd mor e se nsitive a nd the r e is a n inc r e a se d de te c tion of PE

  • f que stiona ble c linic a l sig nific a nc e

 Ca se o f ve no us Do pple r a nd CT

pulmo na ry a ng io g ra m

  • ve ruse (3 c he st sc a ns in a young woma n!)

 Disc uss whe n a ntic o a g ula tio n ma y no t b e re q uire d  Disc uss pra c titio ne r va ria b ility  Re duc e o ve r-inve stig a tio n, o ve rdia g no sis a nd o ve rtre a tme nt

  • f VT

E within yo ur pra c tic e - a r

me d with this ne w knowle dg e , hope fully so!

slide-47
SLIDE 47

Ac kno wle dg e me nts:

 Be no it Ga llix MD PhD (se nio r a utho r, slid e s o n ima g ing

se nsitivity a nd spe c ific ity)

 Ja ro n Cho ng MD (d ra fting o f PE

ma nusc ript)

 Je a n-Ma rc T

ro q ue t MD (d a ta - E R physic ia ns)

 Jo sé A. Co rre a PhD (sta tistic s- PE

pa pe r)

 L

izzy Smyth (d a ta c o lle c tio n)

 L

  • ja n Siva kuma ra n MD (d ra fting o f DVT

ma nusc ript)

 T

  • d d L

e e MD MPH (me nto rship a nd g uid a nc e )

slide-48
SLIDE 48

Que stio ns o r c o mme nts

 e mily.mc do na ld@ mc g ill.c a